ALTH Financial Facts
License and other revenue: 980KInterest and other income, net: 14K
See Full Income Statement
Inventory: 330K
Trade accounts payable: 2.49M
See Full Balance Sheet
Allos Therapeutics, Inc. (ALTH) Earnings
|
Expand Research on ALTH
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +53.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -14.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/12  |
 |
Q411 | -$0.01 | -$0.07 | +$0.06 | $15.4M | $15.94M | N/A |  | | Details |
| 11/2/11 |
|
Q311 | N/A | -$0.15 | N/A | N/A | $12.69M | = | N/A | N/A | |
| 8/4/11 |
|
Q211 | $0.02 | -$0.14 | +$0.16 | $11M | $11.91M | = | | | Details |
| 5/10/11 |
|
Q111 | -$0.14 | -$0.15 | +$0.01 | $10.9M | $12.41M | = | | | Details |
| 3/3/11 |
|
Q410 | -$0.17 | -$0.18 | +$0.01 | $11.7M | $11.23M | = | | | Details |
| 11/4/10 |
|
Q310 | -$0.18 | -$0.21 | +$0.03 | N/A | N/A | N/A | | | Details |
